Posted On: 05/23/2014 8:41:18 AM
Post# of 63761
$PPCH - Propanc Health Group Highlights
-Targeted therapy for metastatic cancer: Global demand for effective, safe and easy to administer cancer treatments increasing rapidly.
-Expansive market demand: Seeking worldwide regulatory approval in several indications, targeting tumor types where few treatment options exist.
-Multiple mechanisms of action: Our lead product exerts multiple effects inhibiting tumor growth & blood supply, and stopping it spreading. R&D may identify opportunities for developing new compounds.
-Encouraging patient data: 15 years of scientific research and clinical experience suggests our lead product may be an effective treatment against cancer and warrants further development.
-Unique intellectual property: Propanc is building an IP portfolio around our scientific understanding of the effects of proenzymes in cancer, new formulations, new routes of
administration and potential new targets
http://www.propanc.com
-Targeted therapy for metastatic cancer: Global demand for effective, safe and easy to administer cancer treatments increasing rapidly.
-Expansive market demand: Seeking worldwide regulatory approval in several indications, targeting tumor types where few treatment options exist.
-Multiple mechanisms of action: Our lead product exerts multiple effects inhibiting tumor growth & blood supply, and stopping it spreading. R&D may identify opportunities for developing new compounds.
-Encouraging patient data: 15 years of scientific research and clinical experience suggests our lead product may be an effective treatment against cancer and warrants further development.
-Unique intellectual property: Propanc is building an IP portfolio around our scientific understanding of the effects of proenzymes in cancer, new formulations, new routes of
administration and potential new targets
http://www.propanc.com
(0)
(0)Scroll down for more posts ▼
